MARKET

BCTX

BCTX

Briacell Therapeutics Corp
NASDAQ
3.191
+0.071
+2.27%
Opening 15:43 05/13 EDT
OPEN
3.110
PREV CLOSE
3.120
HIGH
3.220
LOW
3.050
VOLUME
144.54K
TURNOVER
--
52 WEEK HIGH
34.65
52 WEEK LOW
3.000
MARKET CAP
18.24M
P/E (TTM)
-0.6374
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BCTX last week (0505-0509)?
Weekly Report · 1d ago
Weekly Report: what happened at BCTX last week (0428-0502)?
Weekly Report · 05/05 11:09
BriaCell’s Phase 3 Data Shows Promise for Metastatic Breast Cancer Treatment
TipRanks · 04/30 12:12
Briacell Presents Clinical Data From Pivotal Phase 3 Study Of Bria-IMT, In Metastatic Breast Cancer Supporting Use Of Specific Biomarkers To Predict Patients' Clinical Response To Bria-IMT Treatments
Benzinga · 04/30 11:38
BriaCell presents preclinical data from Phase 3 study of Bria-IMT
TipRanks · 04/30 11:36
Stocks in play: BriaCell Therapeutics Corp.
Barchart · 04/30 08:53
BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified
Barchart · 04/30 06:30
BriaCell Therapeutics Closes $13.8 Million Public Offering
TipRanks · 04/28 20:39
More
About BCTX
More
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.
Recently
Symbol
Price
%Change

Webull offers Briacell Therapeutics Corp stock information, including NASDAQ: BCTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCTX stock methods without spending real money on the virtual paper trading platform.